Altered Frequencies of Dendritic Cells and IFN-γ-secreting T Cells with Granulocyte Colony-Stimulating Factor (G-CSF) Therapy in Acute-on-Chronic Liver Failure

Liver International

Volumn 34, Issue 4, 2014, Pages 505-513

  Khanam, Arshi ^a   Trehanpati, Nirupama ^a   Garg, Vishal ^b   Kumar, Chandan ^a   Garg, Hitendra ^a   Sharma, Barjesh C ^b   Sarin, Shiv K ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

Acute on Chronic Liver Failure; IFN ; Myeloid dendritic cells; Plasmacytoid dendritic cells; T cells

Indexed keywords

BILIRUBIN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PLACEBO; PROCALCITONIN;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOODSTREAM INFECTION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASES; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI INFECTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOTHERAPY; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; T LYMPHOCYTE;

ADULT; CELL COUNT; COHORT STUDIES; DENDRITIC CELLS; END STAGE LIVER DISEASE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 84895816365     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12415     Document Type: Article

References (30)

1. Jalan R, Gines P, Olson JC, et al. Acute-on chronic liver failure. J Hepatol 2012; 57: 1336-48.
2. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009; 3: 269-82.
3. Marsden PA, Ning Q, Fung LS, et al. The Fgl2/fibroleukinprothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 2003; 112: 58-66.
4. Liu M, Chan CW, McGilvray I, et al. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. Expert Rev Mol Med 2001; 3: 1-19.
5. Liu Q, Liu Z, Wang T, et al. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol 2007; 22: 2101-6.
6. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol.2004; 38(Suppl. 3): S158-68.
7. Chan AC, Fan ST, Lo CM, et al. Liver transplantation for acute-on-chronic liver failure. Hepatol Int 2009; 3: 571-81.
8. Liu CL, Fan ST, Lo CM, et al. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation 2003; 76: 1174-9.
9. Bonifaz L, Bonnyay D, Mahnke K, et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196: 1627-38.
10. Kang L, Tomonori I, Marzena S, et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002; 196: 1091-7.
11. Zhao J, Zhang JY, Yu HW, et al. Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy. Cell Mol Immunol 2012; 9: 417-22.
12. Palucka K, Ueno H, Fay J, et al. Harnessing dendritic cells to generate cancer vaccines. Ann NY Acad Sci 2009; 1174: 88-98.
13. Hilkens CM, Isaacs JD, Thomson AW. Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol 2010; 29: 156-83.
14. Anderson AE, Sayers BL, Haniffa MA, et al. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukoc Biol 2008; 84: 124-33.
15. Thomson AW, Robbins PD. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 2008; 67(Suppl III): iii90-6.
16. Zou Z, Li B, Xu D, et al. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol 2009; 43: 182-90.
17. Garg V, Garg H, Khan A, et al. Granulocyte colony-stimulating factor mobilizes CD34 (+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 2012; 142: 505-12.
18. Di Campli C, Zocco MA, Saulnier N, et al. Safety and efficacy profile of G-CSF therapy in patients with acute-on-chronic liver failure. Dig Liver Dis 2007; 39: 1071-6.
19. Fan XP, Zou ZQ, Long B, et al. Enhanced demethylation of IFN-gamma gene promoter in peripheral blood mononuclear cells is associated with acute on chronic hepatitis B liver failure. J Exp Med 2011; 224: 13-9.
20. Robinson RT, Wang J, Cripps JG, et al. End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas. J Immunol 2009; 182: 3278-84.
21. Morris ES, MacDonald KP, Rowe V, et al. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 2004; 103: 3573-81.
22. Rutella S, Bonnano G, Pierelli L, et al. Granulocyte colony stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 2004; 34: 1291-302.
23. Arpinati M, Green C, Heimfeld S, et al. Granulocyte colony-stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 2484-90.
24. Hartung T, Doecke W-D, Gantner F. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 2482-9.
25. Pan L, Delmonte J, Jalonen C, et al. Pretreatment of donor mice with granulocyte colony. Blood 1995; 86: 4422-9.
26. Petit I, Szyper-Kravitz M, Naglar A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and upregulating CXCR-4. Nat Immunol 2002; 3: 687-94.
27. Fujii K, Ishimaru F, Kozuka T, et al. Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor induced peripheral blood stem cell mobilization. Br J Haematol 2004; 124: 190-4.
28. Rutella S, Bonanno G, Procoli A, et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10 ++ IL-12 low/neg accessory cells with dendritic-cell features. Blood 2006; 108: 218-27.
29. Okunishi K, Dohi M, Fujio K, et al. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol 2007; 179: 5504-13.
30. Knight B, Lim R, Yeoh GC, Olynyk JK. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. J Hepatol 2007; 47: 826-33.